We demonstrated that in apoE−/− mice fed a Western diet, hepatic high-level expression of hMsrA reduces plasma VLDL/LDL, improves HDL function and redox status, and suppresses liver and plasma inflammation, resulting in diminished hepatic steatosis and attenuated atherosclerosis. The gene discussed is APOE; the disease is Hepatic steatosis.